Quantum Tunnelling to the Origin and Evolution of Life

Quantum tunnelling is a phenomenon which becomes relevant at the nanoscale and below. It is a paradox from the classical point of view as it enables elementary particles and atoms to permeate an energetic barrier without the need for sufficient energy to overcome it. Tunnelling is being of vital imp

[ read more ]

Mitochondria and the evolutionary roots of cancer

Cancer is a group of almost 200 diseases that involve variety of changes in cell structure, morphology, and physiology. Cancer phenotype is underlying several alterations in cellular dynamics with three most critical features, which includes self-sufficiency in growth signals and insensitivity to in

[ read more ]

Wholeness and implicate order: “Deep” quantum chemistry and cell consciousness: quantum chemistry controls genes and biochemistry to give cells and higher organism’s consciousness and complex behavior

Bohm used the term ‘holomovement’ which is an unbroken and undivided totality and carries an implicate order which is he totality of an order including both the manifested and non-manifested aspects of the order. Non-local quantum phenomena reside in a subtler level than quantum level that is th

[ read more ]

A new theory of the origin of cancer: quantum coherent entanglement, centrioles, mitosis, and differentiation

Low non-specific, low intensity laser illumination (635, 670 or 830 nm) apparently enhances centriole replication and promotes cell division, what is the opposite of a desired cancer therapy. In the contrary, centrioles are sensitive to coherent light. Then higher intensity laser illumination - stil

[ read more ]

Quantum Teleportation and Von Neumann Entropy

From the aspect of the quantum information theories, various quantum entropies are possibly computed at each stage, which ensures the emergence of the entangled states in the intermediate step. If a single qubit quantum teleportation is near the computational basis, the quantum measurement is domina

[ read more ]

Quantum entanglement between the electron clouds of nucleic acids in DNA

Rieper, Anders and Vedral modelled the electron clouds of nucleic acids in a single strand of DNA as a chain of coupled quantum harmonic oscillators with dipole-dipole interaction between nearest neighbours. As a main result, the entanglement contained in the chain coincides with the binding energy

[ read more ]

Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Tomasetti and Vogelstein show that the lifetime risk of cancers of many different types is strongly correlated with the total number of divisions of the normal self-renewing cells maintaining that tissue’s homeostasis. These results suggest that only a third of the variation in cancer risk among t

[ read more ]

A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming Wallace hypothesized mitochondrial dysfunction as a central role in a wide range of age-related disorders and various forms of cancer. Steadily rising increases in mitochondrial DNA mutations cause abr

[ read more ]

Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression

Energy transfer in material solids is driven primarily by differences in intensive thermodynamic quantities such as pressure and temperature. The crucial observation  in quantum-theoretical models was the consideration of the heat capacity as associated with the vibrations of atoms in a crystalline

[ read more ]

About metabolism of a carcinoma cell

Most cancer cells utilize aerobic glycolysis irrespective of their tissue of origin. The alteration from oxidative phosphorylation to glycolysis – called the Warburg effect – is an universal phenomen and has now become a diagnostic tool for cancer detection. Warburg O, Posener K, Negelein E.

[ read more ]

Use of ibuprofen and similar NSAIDs may shorten life of patients with metastatic renal cell carcinoma

Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs‘ promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma (mRCC). (Mehr in: Cancer News — ScienceDaily)

Obesity inhibits key cancer defense mechanism

Obesity could enhance cancer development while aspirin might prevent it — a new insight into potential targets for cancer prevention. (Mehr in: Cancer News — ScienceDaily)

Computer program finds new uses for old drugs

Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy. In a recent study, the researchers successfully translated DrugPredict results into the laboratory, and showed common pain medications — like aspirin — can kill patient-derived epithelial ovarian cancer cells. (Mehr in: Cancer News — ScienceDaily)

Pink und Pille – Neue DASA-Ausstellung "Experiment" zeigt Erfindungen aus dem Chemielabor

Eine Welt ohne Chemie, Arzneimittel und Farbstoffe gibt es nicht mehr. Doch wie entstehen solche Neuerungen? Die neue Ausstellung „Experiment“ beleuchtet ab 10. November in der DASA Arbeitswelt Ausstellung die Hintergründe einflussreicher Erfindungen wie Aspirin, Plastik oder der „Pille“. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)

Can an aspirin a day keep liver cancer away?

A new study found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B related liver cancer. (Mehr in: Cancer News — ScienceDaily)

Targets for better anti-thrombotic medicine identified

Blood thinners, such as aspirin, reduce the risk of thrombus formation but also interfere with the initial clot formation that is essential for preventing blood loss from the wounds. Now researchers have discovered that a molecule plays a role in thrombus development, but not the initial clot formation, suggesting a new avenue for developing more specific and protective blood thinners. (Mehr in: Cancer News — ScienceDaily)

Regular use of aspirin can lower risk of breast cancer for women

The use of low-dose aspirin (81 mg) reduces the risk of breast cancer in women, a new study concludes. Researchers saw an overall 16 percent lower risk of breast cancer in women who reported using low-dose aspirin at least three times per week. (Mehr in: Cancer News — ScienceDaily)

Alternative theory on how aspirin may thwart cancer

Many studies have pointed to a role for aspirin in cancer prevention. Scientists have been unsure how the drug works in this regard, although they usually cite aspirin’s anti-inflammatory effect. Now, lab studies point to a different mechanism. It involves aspirin’s action against platelets, the blood cells that play a role in forming clots — and new blood vessels, which can aid tumor growth. (Mehr in: Cancer News — ScienceDaily)

Regular aspirin use may reduce risk for pancreatic cancer

Regular use of aspirin by people living in Shanghai, China, was associated with decreased risk for developing pancreatic cancer, according to data published. (Mehr in: Cancer News — ScienceDaily)

Colorectal cancer prevention: A proven benefit of nonsteroidal anti-inflammatory drugs

The comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements have now been evaluated in preventing the recurrence of advanced neoplasia (polyps that are the precursor of colorectal cancer) after polyp removal. (Mehr in: Cancer News — ScienceDaily)

Cancer news

New drug halves hearing loss in children following cancer treatment

20. Jun. 2018

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new findings. (Mehr in: Cancer News — ScienceDaily)

- Read more

Competition for space: Oncogenic mutant cells vs normal cells

20. Jun. 2018

Researchers discovered how oncogenic mutant cells selectively expand into surrounding normal tissues and occupy them based on prediction by computer simulation and experimental verification. (Mehr in: Cancer News — ScienceDaily)

- Read more

How pancreatic tumors lead to weight loss

20. Jun. 2018

A study offers insight into the weight loss seen in pancreatic cancer patients, and suggests that weight loss may not necessarily affect patients‘ survival. (Mehr in: Cancer News — ScienceDaily)

- Read more

Towards personalised medicine: One type of data is not enough

20. Jun. 2018

To understand the biology of diseased organs researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalised treatment. (Mehr in: Cancer News — ScienceDaily)

- Read more

New therapeutic opportunity for the treatment of resistant malignant melanoma

20. Jun. 2018

Researchers have revealed that malignant melanoma can reprogram their protein synthesis machinery and become addicted to a new family of enzymes that modify transfer RNAs during acquired resistance. The inhibition of these molecules synergies with targeted therapies to produce a strong anti-tumoral effect. These new findings will be key in the development of improved diagnostic tools and melanoma treatment. (Mehr in: Cancer News — ScienceDaily)

- Read more

Rare in-vivo study shows weak brain nodes have strong influence on memory network

20. Jun. 2018

The majority of existing simulation studies show that the parts of the brain with high connectivity, the so-called ‚hubs‘, are most important when it comes to several different cognitive tasks. But the results of a rare in-vivo study demonstrates that the nucleus accumbens (NAc) — a part of the brain with weak connections — plays an unexpectedly influential role in enhancing the memory network. (Mehr in: Cancer News — ScienceDaily)

- Read more

New tissue-imaging technology could enable real-time diagnostics, map cancer progression

20. Jun. 2018

A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes. It enables researchers to study concurrent processes within cells and tissue, and could give cancer researchers a new tool for tracking tumor progression and physicians new technology for tissue pathology and diagnostics. (Mehr in: Cancer News — ScienceDaily)

- Read more

Putting the brakes on metastatic cancer

20. Jun. 2018

A groundbreaking discovery has identified previously unknown therapeutic targets that could be key to preventing the spread of cancer. Researchers found that by inhibiting several newly identified gene targets they could block more than 99.5 per cent of cancer metastasis in living cells. (Mehr in: Cancer News — ScienceDaily)

- Read more

Long-term estrogen therapy changes microbial activity in the gut

19. Jun. 2018

Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found. (Mehr in: Cancer News — ScienceDaily)

- Read more

The answer to triple-negative breast cancer?

19. Jun. 2018

Researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to Triple Negative Breast Cancer (TNBC), using genetic and treatment data from TNBC cells grown in labs and from hundreds of patients world-wide. Importantly researchers can tell, by inputting patients‘ genomic and proteomic information into their computer model, who may benefit from this drug combination or not — saving precious time. (Mehr in: Cancer News — ScienceDaily)

- Read more

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

19. Jun. 2018

Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease. (Mehr in: Cancer News — ScienceDaily)

- Read more

The force is strong within us: New study explores cell mechanics at work

19. Jun. 2018

A research team focused on measuring the stiffness, bending, twisting and viscosity of individual cells — focused on a breast cancer cell line — using all of the most state-of-the art technology at their disposal. How both healthy and cancerous cells respond to this environment — and whether there are key differences that can be identified for future diagnostic applications was of keen interest to the researchers. (Mehr in: Cancer News — ScienceDaily)

- Read more

Targeting the engine room of the cancer cell

18. Jun. 2018

Researchers have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them. (Mehr in: Cancer News — ScienceDaily)

- Read more

Electrical wire properties of DNA linked to cancer

18. Jun. 2018

New research finds a connection between a cancer mutation and electron-mediated DNA repair. (Mehr in: Cancer News — ScienceDaily)

- Read more

Novel combination as potential therapy for high-risk neuroblastoma

18. Jun. 2018

Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for the disease. (Mehr in: Cancer News — ScienceDaily)

- Read more

Laser-sonic scanner aims to replace mammograms for finding breast cancer

18. Jun. 2018

For women over 40, mammography is a necessary yet annoying procedure to endure every year or two. The technique, while valuable for reducing breast cancer deaths, is less than ideal because it exposes patients to X-ray radiation and requires their breasts to be painfully squished between plates. The plates flatten the breast so the X-rays can more easily pass through it and produce a clear image. (Mehr in: Cancer News — ScienceDaily)

- Read more

Genomics offers new treatment options for infants with range of soft tissue tumors

18. Jun. 2018

The genetic causes of a group of related infant cancers have been discovered by scientists. Whole genome sequencing of tumours revealed mutations which are targetable by existing drugs used to treat lung cancer and melanoma. The results have implications for clinical practice and the diagnosis of rare cancers in infants, and could lead to new, targeted treatment options for these children. (Mehr in: Cancer News — ScienceDaily)

- Read more

Veranstaltungen

10. Stuttgarter Lasertage

01. Jun. 2018

Highlights und Innovationen aus der industriellen Anwendung der Lasertechnik stehen im Mittelpunkt der 10. Stuttgarter Lasertage (SLT 2018), die am 5. und 6. Juni 2018 parallel zur Fachmesse LASYS im Internationalen Congress Center Stuttgart (ICS) stattfinden. Veranstalter sind das Institut für Strahlwerkzeuge (IFSW) der Universität Stuttgart und die Messe Stuttgart. Erwartet werden rund 350 Besucher. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

38. Jahrestagung der Deutschen Gesellschaft für Senologie e.V.

01. Jun. 2018

Unter dem diesjährigen Kongressmotto „4-Ländertagung: Senologie gleich Evolution“ organisiert die Deutschen Gesellschaft für Senologie e.V. (DGS) ihre Jahrestagung erstmalig gemeinsam mit Partnergesellschaften aus Österreich, der Schweiz und Frankreich. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

2nd International Symposium for Molecular Medicine

01. Jun. 2018

Das internationale Symposium für Molekulare Medizin findet zum zweiten Mal in Düsseldorf statt und bringt Wissenschaft und Klinische Praxis im Bereich Orthopädie, Dermatolgie und Alterungsmedizin zusammen. Durch das hochkarätig besetzte Programm führen Prof. Dr. Chris Evans, Genforscher an der Mayo-Klinik Rochester, und Prof. Dr. Martina Kerscher, Inhaberin des Lehrstuhls für Kosmetikwissenschaft an der Universität Hamburg. Workshops ergänzen das Programm. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

2. DGA-Interventionekongress

01. Jun. 2018

Nutzen Sie die Gelegenheit, sich über die Weiterentwicklung von minimalinvasiven Techniken in der Behandlung von Gefäßerkrankungen auf den neuesten Stand zu bringen. Wir möchten außerdem mit Ihnen diskutieren, wie unsere Patienten von neuen Herangehensweisen profitieren können. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

24. Jahrestagung der Deutschen Gesellschaft für Radioonkologie e. V.

01. Jun. 2018

Das wissenschaftliche Programm ist online einsehbar unter http://degro-jahrestagung.de/programm/wissenschaftliches-programm (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

1. World Café 2018 des DGBMT Fachausschusses Usability

01. Jun. 2018

Der DGBMT Fachausschuss Usability befasst sich mit allen Aspekten der Gebrauchstauglichkeit und User Experience in Zusammenhang mit Medizintechnik. Regelmäßig entscheidet der Fachausschuss dabei über neue Schwerpunkte für die kommenden Jahre. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

17. Tag der Arbeitsmedizin in Hamburg

01. Jun. 2018

Dialogforen Arbeitsmedizin und Arbeitssicherheit – Eine Veranstaltungsreihe für Wissenschaft und Praxis von DGAUM und RG GmbH (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen